Oligoadenylate-conjugated benzimidazole-based miR-210 inhibitor for breast cancer

DISEASE CATEGORY: Cancer

INDICATION: Breast cancer

In vitro and cell culture studies suggest a

Read the full 122 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE